Performance of SNY Sanofi ADR | -5.8% in 12m
Compare SNY with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Sanofi ADR with its related Sector/Index XLV
Performance Duell SNY vs XLV
| TimeFrame | SNY | XLV |
|---|---|---|
| 1 Day | -0.31% | 0.19% |
| 1 Week | -1.24% | 1.89% |
| 1 Month | 5.55% | 5.68% |
| 3 Months | 5.39% | 0.84% |
| 6 Months | 3.51% | 15.01% |
| 12 Months | -5.80% | 13.50% |
| YTD | -2.66% | 5.81% |
| Rel. Perf. 1m | 0.15 | |
| Rel. Perf. 3m | -0.90 | |
| Rel. Perf. 6m | -0.72 | |
| Rel. Perf. 12m | -1.87 |
Is Sanofi ADR a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Sanofi ADR (NASDAQ:SNY) is currently (May 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 55.13 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SNY as of May 2024 is 45.20. This means that SNY is currently overvalued and has a potential downside of -7.13% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SNY as of May 2024 is 45.20. This means that SNY is currently overvalued and has a potential downside of -7.13% (Sold with Premium).
Is SNY a buy, sell or hold?
- Strong Buy: 5
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: SNY is performing better - Values below 0%: SNY is underperforming
Compare SNY with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.89% | -0.22% | -14.78% | -35.15% |
| US NASDAQ 100 | QQQ | -3.43% | -0.54% | -13.96% | -43.15% |
| US Dow Jones Industrial 30 | DIA | -2.60% | -0.62% | -11.96% | -27.82% |
| German DAX 40 | DBXD | -0.84% | 0.58% | -13.48% | -22.57% |
| UK FTSE 100 | ISFU | -2.74% | -4.25% | -13.35% | -21.17% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.35% | 1.03% | 0.18% | 1.87% |
| Hongkong Hang Seng | HSI | -4.97% | -17.73% | -1.53% | -0.44% |
| Japan Nikkei 225 | EXX7 | -1.61% | 6.05% | -7.98% | -17.61% |
| India NIFTY 50 | INDA | -4.35% | 1.63% | -14.07% | -34.52% |
| Brasil Bovespa | EWZ | -1.68% | 0.31% | 5.34% | -18.13% |
SNY Sanofi ADR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.24% | 2.24% | -15.00% | -43.28% |
| Consumer Discretionary | XLY | -1.58% | 1.85% | -3.83% | -25.47% |
| Consumer Staples | XLP | -2.00% | -1.03% | -10.73% | -11.38% |
| Energy | XLE | -2.44% | 4.67% | -10.61% | -31.02% |
| Financial | XLF | -2.82% | -1.50% | -18.91% | -38.87% |
| Health Care | XLV | -3.13% | -0.13% | -11.50% | -19.30% |
| Industrial | XLI | -0.96% | 2.07% | -16.18% | -34.13% |
| Materials | XLB | -1.58% | 2.01% | -12.51% | -26.42% |
| Real Estate | XLRE | -3.75% | -2.93% | -6.13% | -15.78% |
| Technology | XLK | -4.30% | -0.97% | -12.81% | -44.11% |
| Utilities | XLU | -2.74% | -7.34% | -14.69% | -18.48% |
| Aerospace & Defense | XAR | -2.01% | -2.91% | -12.03% | -29.95% |
| Biotech | XBI | -4.69% | -2.16% | -22.00% | -12.17% |
| Homebuilder | XHB | -0.92% | -0.79% | -27.00% | -56.65% |
| Retail | XRT | -3.32% | -1.91% | -17.33% | -30.99% |
Does Sanofi ADR outperform its market, is SNY a Sector Leader?
No, over the last 12 months Sanofi ADR (SNY) made -5.80%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.50%.
Over the last 3 months SNY made 5.39%, while XLV made 0.84%.
No, over the last 12 months Sanofi ADR (SNY) made -5.80%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.50%.
Over the last 3 months SNY made 5.39%, while XLV made 0.84%.
| Period | SNY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 5.55% | 5.68% | 5.77% |
| 3 Months | 5.39% | 0.84% | 6.32% |
| 12 Months | -5.80% | 13.50% | 29.35% |